6 results on '"Folks, Thomas"'
Search Results
2. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
- Author
-
Kim, Caryn N., Adams, Debra R., Bashirian, Sheila, Butera, Sal, Folks, Thomas M., and Otten, Ron A.
- Subjects
HIV infections ,SIMIAN viruses ,AIDS ,PRIMATES ,HIV - Abstract
Background Non-human primate models for human immunodeficiency virus (HIV) infection represent a valuable pre-clinical tool to evaluate interventions (e.g., topical microbicides, vaccines, and chemoprophylaxis) designed to prevent transmission or slow disease progression after infection. Standard transmission models use a single-dose exposure with high, non-physiologic levels of virus to approach 100% infection rates of control animals. These single-exposure models do not represent the circumstances of mucosal HIV transmission in humans and may result in misleading data with regard to intervention efficacy. Therefore, we have developed a repetitive mucosal exposure model using doses of virus that better reflects human exposures. Methods The virus used for these evaluations was simian-human immunodeficiency virus [SHIVSF162P3 (R5-using, subtype B HIV-1 envelope)] and the virus dose used (approximately 10
5 โ106 viral particle equivalents or approximately 10 tissue culture infectious doses per exposure) approximates viral loads observed in the semen during acute HIV-1 infection. Using the repeated mucosal exposure approach, we have evaluated a candidate vaginal microbicide (cellulose acetate phthalate, CAP) given 15 minutes prior to each weekly virus exposure. Pig-tailed macaques were exposed weekly by vaginal inoculations with and without microbicide until systemic viral RNA was detected. Results Groups of naïve control monkeys were infected after an average of three to four exposures for the vaginal route of inoculation. Data from the first application of this monkey model to evaluate the topical microbicide CAP suggested that protection from SHIV infection was possible with three of four CAP-treated monkeys remaining uninfected after 12 exposures ( P = 0.015). CAP efficacy was markedly improved from 66% in a previous single-dose virus exposure study to 92% in this repeated exposure system. Conclusion Our experience with using repetitive virus exposures to study topical microbicides and the findings to date from this study provides a basis to refine monkey models to more closely resemble human exposure during HIV transmission. This model may be highly relevant to pre-clinical evaluation for a variety of therapeutic interventions which is discussed here. [ABSTRACT FROM AUTHOR]- Published
- 2006
- Full Text
- View/download PDF
3. Central African hunters exposed to simian immunodeficiency virus.
- Author
-
Kalish, Marcia L., Wolfe, Nathan D., Ndongmo, Clement B., McNicholl, Janet, Robbins, Kenneth E., Aidoo, Michael, Fonjungo, Peter N., Alemnji, George, Zeh, Clement, Djoko, Cyrille F., Mpoudi-Ngole, Eitel, Burke, Donald S., and Folks, Thomas M.
- Subjects
EPIDEMIOLOGICAL research ,SIMIAN viruses ,HIV - Abstract
HIV-seronegative Cameroonians with exposure to nonhuman primates were tested for simian immunodeficiency virus (SIV) infection. Seroreactivity was correlated with exposure risk (p<0.001). One person had strong humoral and weak cellular immune reactivity to SIVcol peptides. Humans are exposed to and possibly infected with SIV, which has major public health implications. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
4. Divergent HIV and Simian Virus Surveillance, Zaire.
- Author
-
Schaefer, Amanda, Robbins, Kenneth E., Nzilambi, Eugene Nzila, St. Louis, Michael E., Quinn, Thomas C., Folks, Thomas M., Kalish, Marcia L., and Pieniazek, Danuta
- Subjects
HIV infections ,SIMIAN viruses ,WESTERN immunoblotting ,ENZYME-linked immunosorbent assay - Abstract
Recent HIV infection or divergent HIV or simian immunodeficiency virus (SIV) strains may be responsible for Western blot-indeterminate results on 70 serum samples from Zairian hospital employees that were reactive in an enzyme immunoassay. Using universal polymerase chain reaction HIV-1, HIV-2, and SIV primers, we detected 1 (1.4%) HIV-1 sequence. Except for 1 sample, no molecular evidence for unusual HIV- or SIV-like strains in this sampling was found. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
5. Frequent Simian Foamy Virus Infection in Persons Occupationally Exposed to Nonhuman Primates.
- Author
-
Switzer, William M., Bhullar, Vinod, Shanmugam, Vedapuri, Mian-er Cong, Vedapuri, Parekh, Bharat, Lerche, Nicholas W., Yee, JoAnn L., Ely, John J., Boneva, Roumiana, Chapman, Louisa E., Folks, Thomas M., and Heneine, Walid
- Subjects
- *
SIMIAN viruses , *AIDS , *PUBLIC health , *OCCUPATIONAL diseases , *VIRAL antibodies , *VIRUSES - Abstract
The recognition that AIDS originated as a zoonosis heightens public health concerns associated with human infection by simian retroviruses endemic in nonhuman primates (NHPs). These retroviruses include simian immunodeficiency virus (SIV), simian T-cell lymphotropic virus (STLV), simian type D retrovirus (SRV), and simian foamy virus (SFV). Although occasional infection with SIV, SRV, or SFV in persons occupationally exposed to NHPs has been reported, the characteristics and significance of these zoonotic infections are not fully defined. Surveillance for simian retroviruses at three research centers and two zoos identified no SIV, SRV, or STLV infection in 187 participants. However, 10 of 187 persons (5.3%) tested positive for SFV antibodies by Western blot (WB) analysis. Eight of the 10 were males, and 3 of the 10 worked at zoos. SFV integrase gene (int) and gag sequences were PCR amplified from the peripheral blood lymphocytes available from 9 of the 10 persons. Phylogenetic analysis showed SFV infection originating from chimpanzees (n = 8) and baboons (n = 1). SFV seropositivity for periods of 8 to 26 years (median, 22 years) was documented for six workers for whom archived serum samples were available, demonstrating long-standing SFV infection. All 10 persons reported general good health, and secondary transmission of SFV was not observed in three wives available for WB and PCR testing. Additional phylogenetic analysis of int and gag sequences provided the first direct evidence identifying the source chimpanzees of the SFV infection in two workers. This study documents more frequent infection with SFV than with other simian retroviruses in persons working with NHPs and provides important information on the natural history and species origin of these infections. Our data highlight the importance of studies to better define the public health implications of zoonotic SFV infections. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
6. Infection of a Laboratory Worker with Simian Immunodeficiency Virus.
- Author
-
Khabbaz, Rima F., Heneine, Walid, George, J. Richard, Parekh, Bharat, Rowe, Thomas, Woods, Toni, Switzer, William M., McClure, Harold M., Murphey-Corb, Michael, and Folks, Thomas M.
- Subjects
- *
SIMIAN viruses , *LABORATORY infections , *IMMUNODEFICIENCY , *LENTIVIRUSES , *HIV , *AIDS , *AIDS vaccines , *MEDICAL records , *HIV infections - Abstract
The article offers information on a laboratory worker with simian immunodeficiency virus (SIV) infection and a study done to investigate the SIV infection in humans. It reports that SIVs are primate lentiviruses that are biologically related to human immunodeficiency viruses (HIVs), and mentions their use in studying the pathogenesis of AIDS and developing an HIV vaccine. It states the development of antibodies that cross-reactive to HIV-2 and SIV in a laboratory worker, after percutaneous exposure to blood, and discusses the studies done on laboratory researchers for HIV and SIV infections. It also discusses the methodology used in the study and presents the medical history of the worker. Also presented are the study's results along with a discussion on SIV infections in humans.
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.